Envestnet Asset Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158K Sell
14,210
-170,560
-92% -$2.07M ﹤0.01% 4686
2026
Q1
$2.58M Buy
184,770
+111,795
+153% +$1.57M ﹤0.01% 2817
2025
Q4
$1.05M Sell
72,975
-134,412
-65% -$2.02M ﹤0.01% 3239
2025
Q3
$3.3M Buy
207,387
+135,474
+188% +$2.23M ﹤0.01% 2540
2025
Q2
$1.27M Sell
71,913
-22,891
-24% -$446K ﹤0.01% 3128
2025
Q1
$1.98M Buy
94,804
+32,270
+52% +$612K ﹤0.01% 2740
2024
Q4
$1.16M Sell
62,534
-108,976
-64% -$2.1M ﹤0.01% 3076
2024
Q3
$3.36M Buy
171,510
+33,440
+24% +$665K ﹤0.01% 2351
2024
Q2
$2.71M Sell
138,070
-61,295
-31% -$1.16M ﹤0.01% 2425
2024
Q1
$3.59M Sell
199,365
-172,551
-46% -$3.13M ﹤0.01% 2210
2023
Q4
$6.3M Buy
371,916
+206,226
+124% +$4.1M ﹤0.01% 1742
2023
Q3
$3.29M Buy
165,690
+30,502
+23% +$578K ﹤0.01% 2084
2023
Q2
$2.54M Buy
135,188
+16,469
+14% +$332K ﹤0.01% 2133
2023
Q1
$2.42M Buy
118,719
+59,152
+99% +$1.19M ﹤0.01% 2076
2022
Q4
$1.26M Buy
59,567
+14,472
+32% +$300K ﹤0.01% 2471
2022
Q3
$917K Buy
+45,095
New +$898K ﹤0.01% 2634
2021
Q1
Sell
-48,604
Closed -$927K 3510
2020
Q4
$927K Buy
48,604
+13,848
+40% +$289K ﹤0.01% 2262
2020
Q3
$820K Buy
34,756
+17,846
+106% +$427K ﹤0.01% 2138
2020
Q2
$412K Buy
+16,910
New +$418K ﹤0.01% 2518

Other funds holding BTAL

Envestnet Asset Management's BTAL Position: Q2 2026 in Review

Envestnet Asset Management reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 92% in Q2 2026, selling an estimated $2.07M and leaving 14,210 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.

Envestnet Asset Management first reported a position in BTAL in Q2 2020 and has held it in 19 quarters since. The position peaked at $6.3M in Q4 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Envestnet Asset Management held 14,210 shares of AGF US Market Neutral Anti-Beta Fund worth $158K as of Q2 2026.
  • Envestnet Asset Management sold 170,560 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $2.07M.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4686 holding.
  • Envestnet Asset Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2020 and has held it in 19 quarters since.
  • Envestnet Asset Management's AGF US Market Neutral Anti-Beta Fund position peaked at $6.3M in Q4 2023.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.